12:00 AM
Feb 22, 2000
 |  BC Week In Review  |  Company News  |  Other News

Altus Biologics Inc. other research news

Altus received a total of $1 million in the form of a Phase II SBIR grant from the National Institute of Diabetes...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >